Botox eyelids: why injections near the eyelid are avoided
The eyelids are not an aesthetic treatment area in the French labels of botulinum toxin. On the contrary, they are an area to protect: toxin that reaches the muscle lifting the eyelid can make it droop, temporarily. Here is why, what the official labels say, and the questions to ask.
The eyelids are one of the eleven areas of our guide to botulinum toxin treatment areas, but in a particular way: this is not an area that is treated, it is an area that is protected. This page explains why, and what you should know when neighbouring areas are treated. It does not replace a consultation.
Why talk about the eyelids?
The upper eyelid is lifted by a small muscle, the levator palpebrae superioris. If botulinum toxin reaches this muscle, it weakens and the eyelid droops: this is called eyelid ptosis3. Yet several commonly treated areas are very close: frown lines, the forehead, the tail of the eyebrow and crow’s feet.
This is why the label of the short-acting botulinum toxin (serotype E) asks to avoid injecting near the muscle that lifts the eyelid, particularly in people whose eyebrow-lowering muscles are very developed, and to place injections in the outer part of the corrugator at least 1 cm above the bony rim of the eye socket1. Type A labels show the same caution: they point out a risk of ptosis, to be limited by respecting doses and the number of injection points2, and ask, for crow’s feet, to inject just under the skin to limit spread6.
What the toxin does not do: it does not treat heavy eyelids caused by excess skin, or under-eye bags. These situations call for other approaches, to be discussed with your doctor.
When is the toxin used near the eyelids?
In the French labels, the toxin is used around the eyelids, never on the eyelid itself: for frown lines, crow’s feet and the forehead, depending on the product2,5,6. An expert consensus published in 2010, written by an expert board convened around one manufacturer’s product, also describes treatment of fine lines on the lower eyelid4; this practice is off-label in France.
Some situations call for caution or contraindicate injection. The label of the short-acting toxin asks for caution when the eyelid is already drooping1. The labels contraindicate injection in case of a generalised disorder of the muscles and of the junction between nerve and muscle (myasthenia gravis, Lambert-Eaton syndrome), allergy to the toxin or an infection at the injection site1,2.
Which toxin for the eyelids?
| Toxin | Status in France |
|---|---|
| Long-acting botulinum toxin (type A) | No aesthetic indication for this area in the SmPCs in force in France: off-label use, to be discussed with your doctor |
| Short-acting botulinum toxin (serotype E) | No aesthetic indication for this area in the SmPCs in force in France: off-label use, to be discussed with your doctor |
Not a treatment area as such: the page explains why injections are avoided here.
Is it a risk for me?
If you are considering treatment of frown lines, the forehead or crow’s feet, your doctor will assess the position of your eyelids and eyebrows before the injection. An eyelid that is already slightly low, asymmetry, or previous eyelid or eyebrow surgery are things to mention: the label of the short-acting toxin asks for the anatomy and any previous procedures to be taken into account1.
Questions to ask your doctor: do my eyelids carry a particular risk? Where will you inject, and how far from the eye? What should I do if an eyelid droops? Whom should I contact in the following days?
Onset and duration
There is no onset to describe for an area that is not treated. The timeline of eyelid ptosis, on the other hand, is known. A review reports that it appears on average 3–14 days after the injection and resolves on its own as the effect of the toxin wears off3. For forehead treatment, one label gives a median onset of 9 days2.
How long ptosis lasts therefore depends on how long the injected toxin works, as explained on the page about how long botulinum toxin takes to work and lasts.
What are the risks around the eyelids?
For neighbouring areas, the labels describe a drooping upper eyelid, eyelid swelling and dry eyes1,2,5. For the short-acting toxin, a drooping eyelid was reported in 0.17% of people treated1. The label also states that a drooping eyelid or a visual disturbance could affect driving1.
If the eyelid droops, eye drops prescribed by a doctor can partly lift it while the effect of the toxin wears off3. The neighbouring areas are covered on the pages about crow’s feet lines, the eyebrow lift and frown lines between the eyebrows.
Difficulty swallowing, speaking or breathing requires immediate medical attention1. A visual disturbance should also be checked by a doctor promptly. To recognise a drooping or swollen eyelid and know what to do, see the page on the eyelids after an injection.
Key points
- The eyelid is not an aesthetic treatment area in the French labels: it is an area to spare1,2.
- Eyelid ptosis comes from the toxin spreading to the muscle that lifts the eyelid3.
- It appears on average 3–14 days after the injection and disappears as the toxin wears off3.
- Tell your doctor about any eyelid that is already low or any previous surgery.
Frequently asked questions
Can botulinum toxin be injected into the upper eyelid for aesthetic purposes?
No French botulinum toxin label provides an aesthetic indication for the eyelid. The labels even ask to avoid injecting near the muscle that lifts the upper eyelid, to limit the risk of it drooping1. The approved neighbouring areas are frown lines and, depending on the product, crow’s feet and the forehead2,5,6. Any other practice around the eye is off-label.
Why can the eyelid droop after an injection?
The eyelid droops when the muscle that lifts the upper eyelid is weakened by toxin that has spread from the injected area, for example from the eyebrow region3. A review also describes an anatomical pathway, present in some people, that makes this passage from the eyebrow easier3. It is a known, temporary side effect.
How long does a drooping eyelid last after botulinum toxin?
According to a review, the eyelid droops on average 3–14 days after the injection and recovers on its own as the effect of the toxin wears off3. Eye drops prescribed by a doctor can partly lift it in the meantime3. If this happens to you, see the doctor who performed the injection; a visual disturbance requires prompt medical attention.
Sources
- 1.Summary of product characteristics of the serotype E botulinum toxin approved in the European Union (EPAR annex I) (opens in a new tab) — European Commission (Union Register of medicinal products)
- 2.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 68150775) (opens in a new tab) — French public medicines database (BDPM)
- 3.Nestor M.S. et al., eyelid ptosis after botulinum toxin: a review, Journal of Cosmetic Dermatology, 2021 (opens in a new tab) — Journal of Cosmetic Dermatology
- 4.Ascher B. et al., international consensus recommendations on type A botulinum toxin in aesthetics, part II: middle and lower face, neck and chest, Journal of the European Academy of Dermatology and Venereology, 2010 (expert board convened around one manufacturer’s product) (opens in a new tab) — Journal of the European Academy of Dermatology and Venereology
- 5.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 66865211) (opens in a new tab) — French public medicines database (BDPM)
- 6.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 61592762) (opens in a new tab) — French public medicines database (BDPM)
- 7.Canadian product monograph of the serotype E botulinum toxin (authorization date: 2026-06-22) (opens in a new tab) — Health Canada